Gel and Blotting Imaging System
more—— News ——
-
![Aniview Support Tumor Theranostics Research: A ternary heterostructured nanocrystal featuring an S-scheme heterojunction for enhanced penetration and ROS-amplified tumor ablation]()
2026/05/04 Aniview Support Tumor Theranostics Research: A ternary heterostructured nanocrystal featuring an S-scheme heterojunction for enhanced penetration and ROS-amplified tumor ablation
New progress has been made in multifunctional nanocatalytic tumor ther
-
![PlantView Support Poplar Rust Resistance Research: Regulation of poplar rust resistance through the interaction between transcription factor PsERF117 and PR10.18]()
2026/05/04 PlantView Support Poplar Rust Resistance Research: Regulation of poplar rust resistance through the interaction between transcription factor PsERF117 and PR10.18
New progress has been made in the molecular regulatory mechanisms of p
-
![Aniview Support Skin Wound Healing and Regenerative Medicine : A Fibrous Scaffold Loaded with BMSC-Derived Apoptotic Bodies Promotes Wound Healing via Inducing Macrophage Polarization]()
2026/04/28 Aniview Support Skin Wound Healing and Regenerative Medicine : A Fibrous Scaffold Loaded with BMSC-Derived Apoptotic Bodies Promotes Wound Healing via Inducing Macrophage Polarization
New progress has been made in skin wound repair and regenerative medic
-
![AACR 2026 - Returning to AACR with New Solutions for Oncology Research]()
2026/04/28 AACR 2026 - Returning to AACR with New Solutions for Oncology Research
From April 17 to 22, 2026, the Annual Meeting of the American Associat
-
![Aniview Support Cancer Immunotherapy Research: Identification of ADAM12 as a Fibroblast Checkpoint via Single-Cell Screening]()
2026/04/28 Aniview Support Cancer Immunotherapy Research: Identification of ADAM12 as a Fibroblast Checkpoint via Single-Cell Screening
New progress has been made in identifying novel targets for cancer imm
-
![Aniview Support Tumor Immunotherapy Research: An Epigenetic Nano-Agonist Promotes T Cell Priming, Recruitment, and Reactivation in PD-L1–Resistant Tumors]()
2026/04/20 Aniview Support Tumor Immunotherapy Research: An Epigenetic Nano-Agonist Promotes T Cell Priming, Recruitment, and Reactivation in PD-L1–Resistant Tumors
New progress has been made in the field of immunotherapy for PD-L1–res
